Free Trial

Orthofix Medical (OFIX) Competitors

Orthofix Medical logo
$13.91 -0.22 (-1.56%)
As of 04:00 PM Eastern

OFIX vs. ATRC, ATEC, IART, SRDX, ANGO, ARAY, RMTI, RSLS, ABT, and ISRG

Should you be buying Orthofix Medical stock or one of its competitors? The main competitors of Orthofix Medical include AtriCure (ATRC), Alphatec (ATEC), Integra LifeSciences (IART), Surmodics (SRDX), AngioDynamics (ANGO), Accuray (ARAY), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), and Intuitive Surgical (ISRG). These companies are all part of the "health care equipment" industry.

Orthofix Medical vs.

AtriCure (NASDAQ:ATRC) and Orthofix Medical (NASDAQ:OFIX) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, community ranking, profitability, analyst recommendations, valuation, risk, institutional ownership and media sentiment.

AtriCure has a net margin of -9.61% compared to Orthofix Medical's net margin of -15.18%. AtriCure's return on equity of -6.80% beat Orthofix Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
AtriCure-9.61% -6.80% -5.19%
Orthofix Medical -15.18%-21.25%-13.29%

AtriCure received 159 more outperform votes than Orthofix Medical when rated by MarketBeat users. Likewise, 69.77% of users gave AtriCure an outperform vote while only 62.20% of users gave Orthofix Medical an outperform vote.

CompanyUnderperformOutperform
AtriCureOutperform Votes
577
69.77%
Underperform Votes
250
30.23%
Orthofix MedicalOutperform Votes
418
62.20%
Underperform Votes
254
37.80%

AtriCure has higher earnings, but lower revenue than Orthofix Medical. AtriCure is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AtriCure$465.31M3.18-$44.70M-$0.95-31.48
Orthofix Medical$799.49M0.68-$151.40M-$3.29-4.23

AtriCure currently has a consensus price target of $50.67, indicating a potential upside of 69.40%. Orthofix Medical has a consensus price target of $23.33, indicating a potential upside of 67.75%. Given AtriCure's higher probable upside, research analysts plainly believe AtriCure is more favorable than Orthofix Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AtriCure
0 Sell rating(s)
0 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
3.00
Orthofix Medical
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, AtriCure had 21 more articles in the media than Orthofix Medical. MarketBeat recorded 24 mentions for AtriCure and 3 mentions for Orthofix Medical. AtriCure's average media sentiment score of 1.08 beat Orthofix Medical's score of 1.07 indicating that AtriCure is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
AtriCure
12 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Orthofix Medical
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

AtriCure has a beta of 1.65, meaning that its share price is 65% more volatile than the S&P 500. Comparatively, Orthofix Medical has a beta of 0.99, meaning that its share price is 1% less volatile than the S&P 500.

99.1% of AtriCure shares are owned by institutional investors. Comparatively, 89.8% of Orthofix Medical shares are owned by institutional investors. 3.5% of AtriCure shares are owned by insiders. Comparatively, 2.6% of Orthofix Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

AtriCure beats Orthofix Medical on 15 of the 17 factors compared between the two stocks.

Get Orthofix Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for OFIX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OFIX vs. The Competition

MetricOrthofix MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$542.80M$4.38B$5.57B$7.82B
Dividend YieldN/A39.98%5.11%4.22%
P/E Ratio-4.4430.6522.4418.48
Price / Sales0.6854.19394.66103.91
Price / CashN/A51.0838.1834.62
Price / Book0.866.116.774.25
Net Income-$151.40M$68.15M$3.22B$248.23M
7 Day Performance3.57%1.33%3.09%3.29%
1 Month Performance-13.39%-4.28%-0.14%2.43%
1 Year Performance7.00%24.22%17.98%5.54%

Orthofix Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OFIX
Orthofix Medical
3.1745 of 5 stars
$13.91
-1.6%
$23.33
+67.7%
+7.9%$542.80M$799.49M-4.441,090Upcoming Earnings
News Coverage
Positive News
ATRC
AtriCure
3.7217 of 5 stars
$31.74
-0.8%
$49.44
+55.8%
+48.3%$1.56B$465.31M-33.411,050Earnings Report
Analyst Forecast
News Coverage
Positive News
Gap Down
ATEC
Alphatec
4.1464 of 5 stars
$10.64
+0.8%
$17.67
+66.0%
-11.0%$1.53B$611.56M-8.31700Upcoming Earnings
Short Interest ↑
IART
Integra LifeSciences
3.9916 of 5 stars
$15.19
-4.0%
$22.71
+49.5%
-40.7%$1.17B$1.61B-168.763,720Upcoming Earnings
SRDX
Surmodics
4.2289 of 5 stars
$28.55
+3.6%
$50.00
+75.1%
+19.7%$408.15M$125.45M-28.27450Earnings Report
Upcoming Earnings
Analyst Forecast
Short Interest ↑
News Coverage
Positive News
Gap Down
ANGO
AngioDynamics
4.2957 of 5 stars
$9.25
-2.8%
$14.00
+51.4%
+64.6%$375.62M$283.32M-1.64760Positive News
ARAY
Accuray
2.8454 of 5 stars
$1.45
-2.0%
N/A-27.0%$149.11M$453.14M-29.001,040Earnings Report
News Coverage
Gap Down
RMTI
Rockwell Medical
4.3354 of 5 stars
$1.02
-1.0%
$4.00
+292.2%
-25.7%$35.20M$101.49M-20.40300Short Interest ↓
RSLS
ReShape Lifesciences
0.4518 of 5 stars
$0.38
+23.7%
N/A-96.3%$4.32M$8.01M-0.0350Short Interest ↑
Negative News
Gap Up
High Trading Volume
ABT
Abbott Laboratories
4.8882 of 5 stars
$130.00
-0.7%
$142.59
+9.7%
+21.7%$225.46B$41.95B16.99115,000Positive News
ISRG
Intuitive Surgical
4.6043 of 5 stars
$468.32
-3.0%
$611.81
+30.6%
+37.6%$166.81B$8.35B73.0612,100Analyst Revision

Related Companies and Tools


This page (NASDAQ:OFIX) was last updated on 4/30/2025 by MarketBeat.com Staff
From Our Partners